Sort
50,496 grants matching “lung cancer”
Therapy for Metastatic breast cancer based on micro RNA silencing
$572,534Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2018 · CA
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$572,521Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer
$572,509Haobin Chen · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Developing an Effective BET bromodomain inhibitor Drug Combo to Target SCLC
$572,509Haobin Chen · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Separation and Analytical Technologies for Proteomics
$572,496Barry L. Karger · Northeastern University · R01 · FY2010 · GM
Integrative molecular and imaging approaches for risk of subtype specific breast
$572,435Randa A El-Zein · Methodist Hospital Research Institute · U01 · FY2017 · CA
Proteomics Biomarkers Development Laboratory
$572,408Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2007 · CA
Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
$572,330Jeanine M. Genkinger · Columbia University Health Sciences · R01 · FY2017 · CA
Development of chemical probe targeting NSD3 SET domain in breast cancer
$572,327Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Development of chemical probe targeting NSD3 SET domain in breast cancer
$572,327Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ
$572,321James G. Herman · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · CA
Targeting Tumors with NF1 Loss
$572,285Yolanda Sanchez · Dartmouth College · R01 · FY2015 · NS
Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity
$572,263Derya Unutmaz · Jackson Laboratory · U19 · FY2021 · AI
Immunotherapeutic responses to neoantigens in head and neck cancer
$572,257Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2022 · DE
Primary screening and hit follow up to identify the first selective inhibitors of PLC?1 and PLC?2
$572,254Zhong-Yin Zhang · Purdue University · R01 · FY2025 · CA
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$572,202Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2022 · CA
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$572,202Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2023 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2025 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2021 · CA
Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogens
$572,159Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2024 · AI
The connection of innate and adaptive anti-cancer immunity
$572,121John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The use of chitosan for cancer vaccine delivery
$572,121John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities
$572,036Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
$571,997Jamie L Studts · University Of Colorado Denver · R01 · FY2024 · CA
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$571,994Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA